<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1597830</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Deletion of the E3 ubiquitin ligase LRSAM1 fosters intracellular <italic>Staphylococcus aureus</italic> survival</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pl&#xf6;hn</surname>
<given-names>Ole</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3146528/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Abhishek Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3146553/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greger</surname>
<given-names>Clara</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wolfgramm</surname>
<given-names>Hannes</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3146626/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baglanova</surname>
<given-names>Madina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3146532/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Surmann</surname>
<given-names>Kristin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2895648/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>V&#xf6;lker</surname>
<given-names>Uwe</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/10390/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Br&#xf6;ker</surname>
<given-names>Barbara M.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/34093/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Becker</surname>
<given-names>Karsten</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/143943/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Seifert</surname>
<given-names>Ulrike</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/31957/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cammann</surname>
<given-names>Clemens</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1229814/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Friedrich Loeffler - Institute of Medical Microbiology, University Medicine Greifswald</institution>, <addr-line>Greifswald</addr-line>,&#xa0;<country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, <addr-line>Greifswald</addr-line>,&#xa0;<country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Immunology, University Medicine Greifswald</institution>, <addr-line>Greifswald</addr-line>,&#xa0;<country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Frank Lafont, Centre National de la Recherche Scientifique (CNRS), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Justin A. Thornton, Mississippi State University, United States</p>
<p>Ghaffar Muharram, Universit&#xe9; de Lille, France</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Clemens Cammann, <email xlink:href="mailto:clemens.cammann@med.uni-greifswald.de">clemens.cammann@med.uni-greifswald.de</email>; Ulrike Seifert, <email xlink:href="mailto:ulrike.seifert@med.uni-greifswald.de">ulrike.seifert@med.uni-greifswald.de</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="other" id="fn004">
<p>&#x2021;These authors share last authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1597830</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Pl&#xf6;hn, Singh, Greger, Wolfgramm, Baglanova, Surmann, V&#xf6;lker, Br&#xf6;ker, Becker, Seifert and Cammann.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Pl&#xf6;hn, Singh, Greger, Wolfgramm, Baglanova, Surmann, V&#xf6;lker, Br&#xf6;ker, Becker, Seifert and Cammann</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Intracellular invasion and persistence of <italic>Staphylococcus aureus</italic> can lead to chronic infection and is an effective strategy for the pathogen to evade the host immune response and antibiotic therapy. Selective ubiquitination of bacterial surfaces via E3 ubiquitin ligases is a mechanism by which host cells combat intracellular bacteria and target them for autophagosomal degradation. However, knowledge of the E3 ligases involved in intracellular recognition of <italic>S. aureus</italic> is still very limited.</p>
</sec>
<sec>
<title>Methods</title>
<p>We studied A549 lung epithelial cells during <italic>S. aureus</italic> infection, focusing on the role of the E3 ligase leucine rich repeat and sterile alpha motif containing 1 (LRSAM1). We used the CRISPR-Cas9 system to generate LRSAM1-deficient A549 cells and monitored intracellular bacterial survival, activation of host cellular signalling pathways related to cytokine production, and host cell death during <italic>S. aureus</italic> infection.</p>
</sec>
<sec>
<title>Results</title>
<p>In LRSAM1-deficient host cells we observed a significant increase in intracellular bacterial load, which was accompanied by an increased host cell death and elevated secretion of the pro-inflammatory cytokine IL-6. Despite induced selective autophagy, LRSAM1 knockout host cells were incapable of lowering and eliminating the pathogen, which seems to be caused by the reduced ubiquitination of the bacterial surface.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The results indicate a significant role of LRSAM1 in the clearance of intracellular <italic>S. aureus</italic>. This contributes to a deeper understanding of the host cellular responses to <italic>S. aureus</italic> infection and will facilitate the development of novel therapeutic strategies to combat intracellularly persistent <italic>S. aureus</italic>.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>S. aureus</italic>
</kwd>
<kwd>ubiquitin</kwd>
<kwd>selective autophagy</kwd>
<kwd>LRSAM1</kwd>
<kwd>intracellular bacteria</kwd>
<kwd>E3 ligase</kwd>
</kwd-group>
<contract-sponsor id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content>
</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="62"/>
<page-count count="12"/>
<word-count count="6897"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Bacteria and Host</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The Gram-positive bacterium <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>) is an opportunistic pathogen responsible for a diverse spectrum of diseases, ranging from minor skin and wound infections to life-threatening systemic disturbances such as bacteremia, septic arthritis, and endocarditis (<xref ref-type="bibr" rid="B56">Tong et&#xa0;al., 2015</xref>). In addition, <italic>S. aureus</italic> is a leading cause of hospital-acquired pneumonia, particularly in intensive care settings, where it is associated with high morbidity and mortality (<xref ref-type="bibr" rid="B8">DeRyke et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B21">Kalil et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B57">Torres et&#xa0;al., 2017</xref>). Furthermore, influenza virus infection can predispose individuals to secondary <italic>S. aureus</italic> pneumonia, resulting in severe coinfections that are characterized by rapid clinical deterioration and poor outcomes (<xref ref-type="bibr" rid="B32">Morris et&#xa0;al., 2017</xref>). Its pathogenicity is based on an extensive, often redundant and multifunctional arsenal of virulence factors as part of the core or accessory genome (<xref ref-type="bibr" rid="B5">Cheung et&#xa0;al., 2021</xref>). Moreover, the pathogen has evolved a variety of strategies to evade immune detection and clearance (<xref ref-type="bibr" rid="B7">de Jong et&#xa0;al., 2019</xref>). An effective strategy for this is to switch to the small-colony variant (SCV) phenotype, which is particularly adapted to an intracellular lifestyle and may lead to persistent and relapsing <italic>S. aureus</italic> infections that are often refractory to antibiotic therapy (<xref ref-type="bibr" rid="B42">Proctor et&#xa0;al., 2006</xref>). Moreover, the treatment of <italic>S. aureus</italic> infections has generally become increasingly challenging due to the emergence of antibiotic-resistant strains, in particular methicillin-resistant <italic>S. aureus</italic> (MRSA) clonal lineages, which compromise the efficacy of conventional antibiotic therapies (<xref ref-type="bibr" rid="B25">Lee et&#xa0;al., 2018</xref>).</p>
<p>One mechanism to evade the host immune response is the intracellular survival and persistence of <italic>S. aureus</italic> in epithelial cells and phagocytes (<xref ref-type="bibr" rid="B52">Strobel et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B46">Rodrigues Lopes et&#xa0;al., 2022</xref>). Elimination of intracellular pathogens relies on host cellular defense mechanisms such as pathogen recognition, ubiquitination by host E3 ligases, and subsequent degradation through selective autophagy. Selective autophagy is a fundamental biological process that targets specific cellular components for degradation in intracellular vesicles, thereby, facilitating cellular homeostasis, efficient recycling of cellular constituents, and adaptation to stress conditions. In the context of infection, studies have demonstrated that selective autophagy plays a pivotal role in the host&#x2019;s defense against intracellular pathogens, including bacteria, viruses, and parasites (<xref ref-type="bibr" rid="B11">Gomes and Dikic, 2014</xref>; <xref ref-type="bibr" rid="B40">Ponpuak et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B50">Shoji-Kawata and Levine, 2009</xref>; <xref ref-type="bibr" rid="B2">Besteiro, 2019</xref>). The recognition of intracellular bacteria for the autophagic machinery requires ubiquitination of the bacterial surface. This posttranslational modification process in which the small protein ubiquitin is covalently attached to bacterial target structures involves a cascade of enzymatic reactions mediated by E1 activating enzymes, E2 conjugating enzymes, and E3 ubiquitin ligases, with E3 ubiquitin ligases providing substrate specificity. When multiple ubiquitin moieties are linked, chains with the length of at least four ubiquitins are formed. These chains can be linked to different internal lysine residues or to the N-terminal methionine of ubiquitin, creating different chain structures that determine the functional outcome of the attached protein substrates influencing the cellular response (<xref ref-type="bibr" rid="B22">Komander and Rape, 2012</xref>).</p>
<p>During selective autophagy the ubiquitin chains attached to the pathogen can be recognized by autophagic adaptor proteins such as the ubiquitin-binding proteins p62/sequestosome-1 (SQSTM1), and nuclear dot protein 52 (NDP52). These proteins function as molecular bridges, thereby, linking ubiquitinated pathogens to the autophagosomal membrane through interactions with the microtubule-associated protein 1A/1B-light chain 3 (LC3) (<xref ref-type="bibr" rid="B24">Lamark et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B45">Ravenhill et&#xa0;al., 2019</xref>). LC3 plays a pivotal role in autophagy by facilitating the formation of autophagosomes through its lipidated form, LC3-II, which associates with autophagosomal membranes. Through further interactions with autophagy adaptor proteins, LC3 ensures the selective degradation of ubiquitinated pathogens, which is finally realized by the fusion of autophagosomes with cellular lysosomes (<xref ref-type="bibr" rid="B49">Sharma et&#xa0;al., 2018</xref>). The concept of bacterial surface ubiquitination was initially introduced in the context of <italic>Salmonella</italic> and <italic>Listeria</italic> infection, where it was identified as a cellular prerequisite for pathogen recognition and subsequent clearance (<xref ref-type="bibr" rid="B38">Perrin et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B3">Birmingham et&#xa0;al., 2006</xref>). In the last decade, similar ubiquitination processes have been described for <italic>Mycobacterium tuberculosis</italic> (<xref ref-type="bibr" rid="B61">Watson et&#xa0;al., 2012</xref>), <italic>Francisella tularensis</italic> (<xref ref-type="bibr" rid="B6">Chong et&#xa0;al., 2012</xref>), and <italic>S. aureus</italic> (<xref ref-type="bibr" rid="B33">Neumann et&#xa0;al., 2016</xref>). However, the knowledge about the E3 ubiquitin ligases involved in this process is still limited.</p>
<p>In this study, we investigated the function of the E3 ubiquitin ligase leucine rich repeat and sterile alpha motif containing 1 (LRSAM1), which has been previously implicated in the ubiquitination of the Gram-negative bacterium <italic>Salmonella</italic> Typhimurium (<xref ref-type="bibr" rid="B19">Huett et&#xa0;al., 2012</xref>). Our objective was to elucidate the impact of LRSAM1 on the fate of intracellular <italic>S. aureus</italic>. Our findings reveal a pivotal role for LRSAM1 in the elimination of intracellular bacteria, offering novel insights into the intricate mechanisms that govern intracellular bacterial clearance.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Cell lines</title>
<p>The human alveolar epithelial cell line A549 (<xref ref-type="bibr" rid="B26">Lieber et&#xa0;al., 1976</xref>) was cultivated in RPMI1640 (Gibco) medium containing 10% fetal calf serum (FCS, Capricorn).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Bacterial strains</title>
<p>
<italic>S. aureus</italic> HG001 strain (<xref ref-type="bibr" rid="B17">Herbert et&#xa0;al., 2010</xref>), a derivative of the NCTC 8325 strain with a repaired sigma B regulation factor (RsbU<sup>+</sup>) that restores full functionality of the stress sigma factor SigB, was maintained in tryptic soy broth (TSB, Roth) or on blood agar plates (BD Biosciences) at 37&#xb0;C. The HG001-pMV158GFP (HG001-GFP) strain was generated as described before (<xref ref-type="bibr" rid="B35">Nieto and Espinosa, 2003</xref>) and plasmid maintenance was assured by addition of 20 &#xb5;g/ml tetracycline to the culture medium. The HG001- pMV158GFP&#x394;<italic>spa</italic> strain (generated by S. Engelmann and J. Pan&#xe9;-Farr&#xe9;), used in order to prevent unspecific antibody staining in flow cytometry by binding of <italic>S. aureus</italic> Protein A to the Fc region of antibodies, was maintained by addition of 10 &#xb5;g/ml erythromycin and 20 &#xb5;g/ml tetracycline to the culture medium.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>CRISPR-Cas9 genomic editing</title>
<p>CRISPR-Cas9 genomic editing for gene deletion was performed as previously described (<xref ref-type="bibr" rid="B43">Ran et&#xa0;al., 2013</xref>), using pSpCas9(BB)-2A-Puro (PX459) V2.0, a kind gift from Feng Zhang (Addgene plasmid #62988; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene:62988">http://n2t.net/addgene:62988</ext-link>; RRID: Addgene_62988). For <italic>LRSAM1</italic> gene deletion the sgRNA sequence 5&#xb4;- CGTTCCATTGGGAACCTGAC-3&#xb4; targeting Exon 8 and for control cells non-targeting sgRNA 5&#xb4;- ACATAGTCGACGGCTCGATT -3&#xb4; was cloned into the pSpCas9 (BB)-2A-Puro plasmid (pX459) and transfected into A549 cells. At 48 h transfected cells containing <italic>LRSAM1</italic>-specific and non-targeting sgRNA were placed under puromycin selection (5 &#xb5;g/ml) for 2 days and afterwards diluted to single cells. Clones recovered post single cell dilution were picked, grown, and screened by immunoblot analysis. Additionally, genomic DNA was purified and amplified by PCR using the primers <italic>LRSAM1</italic>_for 5&#xb4;- GCCGGTAGGGGGAGATAAGA-3&#xb4; and <italic>LRSAM1</italic>_rev 5&#xb4;-GATGGAGGGTCACACGGAC-3&#xb4; designed to flank the site targeted by the sgRNA. The PCR products were validated by sequencing.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Infection of A549 cells</title>
<p>Infections were carried out as described before with minor adaptations (<xref ref-type="bibr" rid="B37">Palma Medina et&#xa0;al., 2019</xref>). In brief, prior infection of confluent epithelial cells, bacteria were grown in TSB medium up to an OD<sub>600</sub> of 0.8 - 2. Bacteria were transferred to a pre-culture with a starting OD<sub>600</sub> of 0.05 in RPMI1640 medium and grown to an OD<sub>600</sub> of 0.3-0.5, to adapt the bacteria to the infection medium. The starting OD<sub>600</sub> of the subsequent main culture was set to 0.05 and it was incubated for &#x223c;2 h at 150 rpm and 37&#xb0;C until it reached the mid-exponential phase at an OD<sub>600</sub> of 0.4. We subsequently counted the cells from a separate well and calculated the volume of the bacterial culture to reach the desired MOI. The bacteria were then harvested accordingly and used for preparation of the master mix for infection. For preparation of fixed <italic>S. aureus</italic> HG001-GFP, the main culture was harvested at OD<sub>600</sub> of 0.4 centrifuged and resuspended in PBS containing 2% paraformaldehyde (PFA, Applichem), incubated for 30 min at room temperature and subsequently washed with PBS to remove residual PFA and finally resuspended in RPMI. All infections were carried out at a multiplicity of infection of 10 (MOI 10) bacteria per host cell. The master mix for infection was prepared from a mid-exponential (OD<sub>600</sub> of 0.4) culture of <italic>S. aureus</italic> HG001 diluted in RPMI, buffered with 2.9 &#x3bc;l sodium hydrogen carbonate (7.5%, PAN-Biotech GmbH) per ml bacterial culture added. A549 cells were seeded one day prior to infection in six-well plates. On the day of infection, the growth medium over the confluent epithelial layer was replaced with the infection master mix, and the co-culture was incubated for 1 h at 37&#xb0;C in 5% CO<sub>2</sub>. Afterwards, the medium containing non-adherent bacteria was collected and replaced with fresh RPMI 1640 containing 10 &#xb5;g/ml lysostaphin (Sigma) to follow up the internalization but avoiding reinfection. The infections were continued until the chosen time points and then processed for further analysis.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Colony forming unit determination</title>
<p>Cells were lysed at 0.5 h, 1 h, 2 h, 3 h, 5 h and 7 h post infection through hypotonic lysis using bidistilled water (<italic>Aqua bidest</italic>.) for 30 min. Serial dilutions from 10<sup>-3</sup> &#x2013; 10<sup>-5</sup> of the released bacteria in <italic>Aqua bidest.</italic> were plated on blood agar plates. CFU counts were determined after 24 h incubation at 37&#xb0;C and the mean CFU numbers were calculated from all dilutions. For normalization, a technical replicate of the infected cells was harvested using 1% trypsin (Capricorn Scientific) and subsequently counted using trypan blue staining to exclude dead cells in a counting chamber (Neubauer). Finally, CFUs were normalized to 1 x 10<sup>5</sup> viable cells.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Fluorescence microscopy</title>
<p>Cells were seeded in 12-well cell culture plates containing autoclaved glass cover slips (Sarstedt). Infection with <italic>S. aureus</italic> HG001 (MOI 10) was carried out as described above (2.1.4.). At 3 h post infection cells were washed with PBS and subsequently fixed with 2% paraformaldehyde in PBS for 10 min. After fixation, the cells were washed twice with PBS and then permeabilized with 1 mL per well of 0.1% Triton X-100 in phosphate-buffered saline (PBS, Th. Geyer) for 5 minutes at room temperature. After subsequent washing with PBS cells were stained as described before (<xref ref-type="bibr" rid="B18">Hildebrandt et&#xa0;al., 2016</xref>) with the staining solution containing 1 &#xb5;g/ml HOECHST 33258 (Sigma-Aldrich), 3 U/ml Flash Phalloidin-red 594 (Biolegend) and 0.4 &#xb5;g/&#xb5;l Vancomycin, BODIPY&#x2122; FL Conjugate (Thermo Fisher Scientific) and incubated for 10 min at room temperature in the dark. After staining the cells were washed twice with PBS and once with <italic>Aqua bidest.</italic> The cover slips were transferred to an object slide with Fluorescent Mounting Medium (DAKO). Pictures were acquired for each cover slip using a REVOLVE microscope (Discover Echo) and processed with the included Echo Pro software.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Flow cytometry</title>
<p>Cells were harvested using 1% trypsin (Capricorn Scientific) at indicated time-points post infection. Cells infected with <italic>S. aureus</italic> HG001-pMV158GFP were washed once with PBS and directly measured via flow cytometry. For ubiquitin staining of <italic>S. aureus</italic> HG001-pMV158GFP &#x394;<italic>spa</italic>, infected cells were treated with <italic>Aqua bidest</italic>. for 30 min, and subsequently centrifuged at 10000 g for 2 min, washed once with PBS and stained with anti-ubiquitin (P4D1)-Alexa 647 antibody (Santa Cruz) for 20 min in the dark. For ubiquitin chain-specific staining cells were stained with primary antibodies for K48- and K63-ubiquitin chains (all Cell Signaling Technology) for 30min and after subsequent washing stained with anti-rabbit-Alexa-647 secondary antibody (Abcam) for 30min. The background staining of the secondary antibody was evaluated using the secondary antibody alone as a control, with no primary antibodies present. Data were acquired using a MACSQuant Analyzer 10 Flow Cytometer (Miltenyi Biotec) and analyzed with FlowJo&#x2122; Version 10.6.0 software. For assessing the bacteria, the FSC and SSC triggers were set to 0, due to the small size of the bacteria.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Immunoblot analysis</title>
<p>Proteins were isolated using TRIzol<sup>&#xa9;</sup> reagent (Thermo Fisher Scientific) according to manufacturer&#xb4;s instructions and quantified via Bradford assay. For immunoblotting proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes. After subsequent blocking with ROTI<sup>&#xae;</sup>Block (Carl Roth GmbH) membranes were analyzed for target proteins using primary antibodies for PARP, cleaved PARP, LRSAM1, pI&#x3ba;B&#x3b1;, I&#x3ba;B&#x3b1;, LC3, pMLKL, MLKL and &#x3b2;-actin (all Cell Signaling Technology). After incubation with primary antibodies membranes were incubated for 60 min at RT with species-specific and horseradish peroxidase-coupled secondary antibodies. Membranes were developed with chemiluminescence using SignalFire&#x2122; ECL Reagent (Cell Signaling Technology) and analyzed with Imagequant 800 system (Cytiva).</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Cell viability assays</title>
<p>The monitoring of cell viability was performed by analyzing the LDH content in cell supernatants by CytoTox-ONE Homogeneous Membrane Integrity Assay (Promega) according to manufacturer&#x2019;s protocol. In brief, 50 &#xb5;L of supernatants were incubated for 10 min with 50 &#xb5;L substrate solution. Afterwards the reaction was stopped by adding 25 &#xb5;L of Stop solution. Supernatants of non-infected cells treated for 10 min at 37&#xb0;C with 10% TritonX 100 (AppliChem) served as positive control reflecting 100% cell death. Samples were measured at 590 nm using a plate reader (Tecan).</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Cytokine analysis</title>
<p>ELISA for IL-6 (BioLegend) was performed according to manufacturer&#x2019;s instructions. In brief, plates were coated with the included capture antibody and incubated for 16-18 h at 4&#xb0;C. Plates were washed (PBS + 0.5% Tween-20). Hereafter, plates were blocked with blocking solution for 1 h with shaking at 500 rpm. Furthermore, standard series were prepared (IL-6, 500 pg/ml &#x2013; 7.8 pg/ml). Non-specific bindings were blocked, blocking solution was removed and plates were washed. Standards and cell culture medium samples were added to the plates and incubated for 2 h with shaking. After the plates were washed, they were incubated with the biotinylated detection antibody for 1 h. The detection antibody solution was removed, and plates were washed again. Avidin-HRP solution was added and incubated for 30 min with shaking. Avidin-HRP solution was removed, and plates were washed again. TMB substrate solution was added and incubated for 15 min in the dark. Stop solution (2 N H<sub>2</sub>SO<sub>4</sub>) was added and absorbance was measured at 450 nm within 15 min.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Cathepsin B measurement</title>
<p>To assess cellular cathepsin B activity cells were lysed post infection using 10 mM Tris-HCl (pH 7.0), 10 mM NaCl, 25 mM KCl, 1 mM MgCl<sub>2</sub>, 10% Glycerol and 1mM Dithiothreitol (DTT) with three repeated freeze-thaw cycles of 15s incubation in liquid nitrogen and 3 min at 37&#xb0;C. Protein concentration was determined via Bradford assay. The enzyme reaction was started by adding the substrate R-R-AMC (Bachem) to 2 &#xb5;g protein lysate in assay buffer containing 100 mM Na-acetate (pH 5.5), 5 mM CaCl<sub>2</sub> and 10 mM DTT as described before (<xref ref-type="bibr" rid="B48">Sendler et&#xa0;al., 2016</xref>). Enzyme kinetics were measured 0 &#x2013; 1 h using a fluorescence plate reader (Tecan) with an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Calculated values are presented as change in relative fluorescence per minute compared to baseline.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<p>The objective of this study was to assess the role of LRSAM1 in the recognition and clearance of intracellular <italic>S. aureus</italic> HG001 by infected human alveolar epithelial cells. To this end, a CRISPR-CAS9-mediated deletion for LRSAM1 was generated in A549 lung epithelial cells (clones #A4 and #A9, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). Given that A549 epithelial cells are non-professional phagocytic cells, we hypothesized that the deletion of LRSAM1 would have an effect on the uptake and amount of intracellular bacteria. To test this, wild-type (non-targeted control, NTC) and LRSAM1-deficient cells (clone #A9) were infected with <italic>S. aureus</italic> HG001, and analyzed for the bacterial intracellular life style as done before (<xref ref-type="bibr" rid="B54">Surmann et&#xa0;al., 2015</xref>). Intracellular bacteria were stained with fluorescence-labelled vancomycin, BODIPY&#x2122; FL, and were monitored via fluorescence microscopy. The results demonstrated an increased intracellular bacterial load in LRSAM-deficient cells at 3 h post infection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Higher intracellular bacterial load upon deletion of LRSAM1 in A549 epithelial cells. <bold>(A)</bold> CRISPR CAS9 mediated deletion of LRSAM1 was confirmed by immunoblot for clone #A9 and #A4 and compared to control cells (A549 wt and A549 NTC). <bold>(B)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001 (MOI 10) and subsequently stained with HOECHST 33258 &#x2013; nucleus, Flash Phalloidin-red 594 &#x2013; F-actin and Vancomycin, BODIPY&#x2122; FL Conjugate - bacteria for fluorescence microscopy 3 h post infection, n = 3, magnification 60x, scalebar 20 &#xb5;m <bold>(C)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001 (MOI 10), cells were lysed at the depicted time-points and the released bacteria were plated on blood agar plates for determination of the colony forming units (CFU), data is represented as mean &#xb1; SD of three replicates. Statistical significance is indicated (*p&lt;0.05, **p&lt;0.01, students t-test) <bold>(D)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001-GFP (MOI 10) and analyzed for the number of infected cells by flow cytometry at the depicted time points. <bold>(E)</bold> Data analysis is represented as mean &#xb1; SD of three replicates. Statistical significance is indicated (**p&lt;0.01, students t-test). <bold>(F)</bold> The ratio between infected LRSAM1-deficient and infected NTC cells is depicted for 1 h and 3 h upon infection. Ratios are presented as mean &#xb1; SD of three replicates. Statistical significance is indicated (*p&lt;0.05, students t-test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1597830-g001.tif">
<alt-text content-type="machine-generated">Composite image containing multiple panels:   (A) Western blot showing LRSAM1 and &#x3b2;-actin protein levels in A549 wild type, A549 NTC, clone #A9(-), and clone #A4(-).  (B) Microscopy images depicting nuclei in blue, F-actin in red, S. aureus HG001 in green, and merged images for A549 NTC and clone #A9(-).  (C) Bar graph showing CFU of A549 NTC and clone #A9(-) at various hours post-infection.  (D) Flow cytometry plots indicating percent of HG001-GFP+ cells over time for A549 NTC and clone #A9(-).  (E) Bar graph comparing percent HG001-GFP+ cells at 1 and 3 hours post-infection for A549 NTC and clone #A9(-).  (F) Bar graph comparing infected cells in clone #A9(-) relative to NTC at 1 and 3 hours post-infection.</alt-text>
</graphic>
</fig>
<p>To address the question whether the intracellular bacteria are still viable, we lysed the host cells and plated the non-stained bacteria on blood agar plates to determine the colony forming units (CFUs). Infection of both LRSAM1 KO and NTC cells showed a marked increase in viable intracellular bacteria at 0.5 h, 1 h and 2 h, followed by decreased bacterial loads at 3 h and 5 h. Throughout the infection, LRSAM1 KO clones #A9 and #A4 consistently exhibited higher intracellular CFU counts compared to control cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1C</bold>
</xref>).</p>
<p>Next, we investigated whether the increased bacterial load observed in LRSAM1 knockout cells was attributable to enhanced invasion and/or improved intracellular survival of <italic>S. aureus</italic>. Since we removed all extracellular bacteria 1 hour after infection by adding lysostaphin, <italic>S. aureus</italic> invasion can only occur during the first hour of infection. Within this timeframe, we observed a significant rise in intracellular bacteria, coupled with a slight decrease in CFUs of extracellular bacteria in the infection medium of the LRSAM KO cells compared to NTC cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1D</bold>
</xref>). At later time points investigating <italic>S. aureus</italic> intracellular survival by infecting the cells with the HG001-GFP strain, we demonstrated that a higher percentage of host cells was infected 1 h post-infection than 3 h post-infection, with a significantly higher rate of infected cells in LRSAM1-deficient than in NTC cells (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D, E</bold>
</xref>). In addition, an increase in the ratio of infected LRSAM1-deficient to NTC cells was observed from 1 h to 3 h post infection, indicating reduced clearance of intracellular <italic>S. aureus</italic> in the LRSAM1-deficient cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). These results suggest that LRSAM1-deficient cells have an increased susceptibility to <italic>S. aureus</italic> invasion and an inability to clear intracellular bacteria compared to control cells. To address the question of whether <italic>S. aureus</italic> must be viable to exhibit this phenotype, we infected cells with PFA-fixed <italic>S. aureus</italic> HG001-GFP. We observed only a very low number of intracellular bacteria, with no difference between the LRSAM1 KO and NTC (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1E</bold>
</xref>).</p>
<p>To determine whether the elevated bacterial load and infection rate impact host cellular survival, we investigated cell death induction during infection. By assessing extracellular LDH release, we observed an elevated cell death 3 h, 5 h, and 7 h post infection in LRSAM1-deficient cells compared to NTC cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). It is known from previous studies that <italic>S. aureus</italic> infection can induce apoptosis and necroptosis in the host cells (<xref ref-type="bibr" rid="B16">Haslinger-L&#xf6;ffler et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B14">Greenlee-Wacker et&#xa0;al., 2017</xref>). To further refine the observed increased cell death, we analyzed the cleavage of the apoptotic marker poly(ADP-ribose)-polymerase (PARP) and the phosphorylation of mixed lineage kinase domain like pseudokinase (MLKL), which is a hallmark in necroptosis. Levels of both markers were significantly increased in infected LRSAM1 knockout cells compared to NTC cells. These results indicate <italic>S. aureus</italic>-specific induction of host cell death in LRSAM1-deficient cells (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B-D</bold>
</xref>). Furthermore, infection with PFA-fixed bacteria had no impact on the induction of cell death in either LRSAM1-deficient cells or NTCs (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2B, C</bold>
</xref>). This suggests that active expression of virulence factors is necessary for this process.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Increased cell death in infected LRSAM1-deficient cells. <bold>(A)</bold> Host cell death was monitored upon infection with <italic>S. aureus</italic> HG001 (MOI 10) by determining extracellular lactate dehydrogenase (LDH) at the depicted time-points comparing LRSAM1 KO (clone #A9) and control cells (A549 NTC). Data are represented as mean &#xb1; SD of three replicates. Statistical significance is indicated (*p&lt;0.05, **p&lt;0.01, students t-test) <bold>(B)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001 (MOI 10) for the depicted time-points and subsequently analyzed for PARP cleavage and phosphorylation of MLKL and total MLKL by immunoblotting with &#x3b2;-actin as loading control. Band intensities were analyzed by densitometry. Cleaved PARP was normalized to the loading control &#x3b2;-actin and phosphorylated MLKL was normalized to MLKL and the loading control &#x3b2;-actin. Graph depicts relative cleaved PARP <bold>(C)</bold> and relative phosphorylation of MLKL <bold>(D)</bold> in LRSAM1 KO (clone #A9) and control cells (A549 NTC) calculated to the respective non-infected control. Data are represented as mean &#xb1; SD of three replicates. Statistical significance is indicated (*p&lt;0.05, students t-test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1597830-g002.tif">
<alt-text content-type="machine-generated">Bar graphs and Western blot images compare cytotoxicity, PARP cleavage, and MLKL phosphorylation between A549 NTC and clone #A9(-) after S. aureus HG001 infection at 3, 5, and 7 hours. Significant increases are noted in clone #A9(-). </alt-text>
</graphic>
</fig>
<p>
<italic>S. aureus</italic> virulence factors such as protein A or &#x3b1;-toxin can trigger MAPkinase pathways, which in turn lead to the activation of transcription factors such as NF&#x3ba;B (<xref ref-type="bibr" rid="B12">G&#xf3;mez et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B44">R&#xe4;th et&#xa0;al., 2013</xref>). This activation is followed by an induction and secretion of pro-inflammatory cytokines like IL-6, which mediates the recruitment of innate immune cells like neutrophils and macrophages to the site of infection (<xref ref-type="bibr" rid="B34">Ngo et&#xa0;al., 2022</xref>). During infection of LRSAM1-deficient cells, a significant increase in IL-6 secretion was observed compared to NTC cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2D</bold>
</xref>). Since the secretion of IL-6 is dependent on the activation of the NF&#x3ba;B-pathway, we addressed the question if LRSAM1-deficiency impacts NF&#x3ba;B induction by assessing the expression level of the NF&#x3ba;B-inhibitory protein I&#x3ba;B&#x3b1; and its phosphorylation. The results demonstrated an increase in I&#x3ba;B&#x3b1; degradation as well as an increased phosphorylation of I&#x3ba;B&#x3b1; during infection in LRSAM1-deficient cells (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B&#x2013;D</bold>
</xref>), indicating an elevated activity of the NF&#x3ba;B-pathway with increased secretion of IL-6 upon infection.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Elevated levels of secreted IL-6 in LRSAM1-deficient cells during infection. <bold>(A)</bold> Secretion of IL-6 was determined by ELISA for the depicted time points in cell culture supernatants of LRSAM1 KO (clone #A9) and control cells (A549 NTC) during infection with <italic>S. aureus</italic> HG001 (MOI 10). Data are represented as mean &#xb1; SD of three replicates. Statistical significance is indicated (**p&lt;0.01, ***p&lt;0.001, students t-test) <bold>(B)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001 (MOI 10) for the depicted time-points and subsequently analyzed for pI&#x3ba;B&#x3b1; and I&#x3ba;B&#x3b1; by immunoblotting with &#x3b2;-actin as loading control. <bold>(C)</bold> Band intensities of I&#x3ba;B&#x3b1; were analyzed by densitometry and normalized to the loading control &#x3b2;-actin. Graph depicts relative I&#x3ba;B&#x3b1; in LRSAM1 KO (clone #A9) and control cells (A549 NTC) calculated to the respective non-infected control, Data are represented as mean &#xb1; SD of three replicates. <bold>(D)</bold> Band intensities of pI&#x3ba;B&#x3b1; were analyzed by densitometry and normalized to the loading control &#x3b2;-actin. Graph depicts relative pI&#x3ba;B&#x3b1; in LRSAM1 KO (clone #A9) and control cells (A549 NTC) calculated to the respective non-infected control, Data are represented as mean &#xb1; SD of three replicates. Statistical significance is indicated (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, students t-test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1597830-g003.tif">
<alt-text content-type="machine-generated">Graphical and tabular data detailing the response of A549 cells and clone #A9(-) to S. aureus HG001 infection. Panel A shows IL-6 production over time, with increased levels in clone #A9(-) + HG001. Panel B presents a Western blot of pI&#x3ba;B&#x3b1; and I&#x3ba;B&#x3b1; at various times, indicating changes in protein expression. Panel C shows relative I&#x3ba;B&#x3b1; abundance, with differences at 3 hours. Panel D displays relative I&#x3ba;B&#x3b1; phosphorylation, showing increased levels in clone #A9(-) + HG001 at all times. Statistical significance is marked by ** and ***.</alt-text>
</graphic>
</fig>
<p>Given the observation of an accumulation of intracellular <italic>S. aureus</italic> in LRSAM1-deficient cells, we asked whether ubiquitination and selective autophagy were impaired in these cells. Ubiquitination of the bacterial surface is a crucial prerequisite for the recognition and subsequent elimination of intracellular bacteria. To test this, intracellular bacteria were isolated from infected host cells, stained with an anti-ubiquitin antibody and analyzed via flow cytometry. For this analysis, we used the <italic>S. aureus</italic>-GFP&#x394;<italic>spa</italic> strain to prevent non-specific binding of the antibodies to Protein A. This strain exhibited a comparable intracellular bacterial phenotype to that of the wild-type <italic>S. aureus</italic> HG001 strain (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>; <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). The results indicated that bacterial ubiquitination was significantly reduced in LRSAM1 KO cells (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). Moreover, we could observe the formation of both K48 and K63 ubiquitin chains at the bacterial surface, which was reduced in the LRSAM1 KO cells to a similar extent (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3C</bold>
</xref>).To analyze whether the reduced ubiquitination has an impact on subsequent autophagy induction we examined the conversion of the autophagy marker LC3-I to LC3-II by immunoblotting. We observed an enhanced LC3-II formation in infected LRSAM1-deficient cells compared to NTC cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). These observations suggest that the elevated intracellular bacterial load increased autophagic activity. However, due to reduced ubiquitination, the bacteria could not efficiently be removed from the cells through autophagy. To validate whether the increase in LC3-II resulted from an enhanced autophagic flux or a block in autophagy downstream, we added the lysosomal inhibitor bafilomycin A1 during the infection. A substantial increase in LC3-II in the bafilomycin-treated samples is evidence against a block of autophagy, indicating an elevated autophagic turnover in the infected cells (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4D</bold>
</xref>). Furthermore, we measured the activity of cathepsin B, a lysosomal protease necessary for intracellular proteolysis and elimination of bacteria in (auto-)phagosomal vesicles. We observed an increase in cellular cathepsin B activity in LRSAM1-deficient cells upon infection, which confirmed the higher activity of autophagy in these cells compared to NTC control cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3D</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>LRSAM1-deficient cells show induced cellular autophagy in response to <italic>S. aureus</italic> infection. <bold>(A)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001-GFP&#x394;<italic>spa</italic> (MOI 10), which was used to prevent unspecific binding of the anti-ubiquitin antibody to <italic>S. aureus</italic> Protein A, and lysed 3 h post infection. Released intracellular bacteria were analyzed for ubiquitination by staining with anti-APC-ubiquitin antibody and subsequent flow cytometry analysis by gating on 1000 GFP-positive bacteria in total. <bold>(B)</bold> Graph depicts the percentage of ubiquitinated intracellular <italic>S. aureus</italic>, n = 4, statistical significance is indicated (***p&lt;0.001, students t-test). <bold>(C)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were infected with <italic>S. aureus</italic> HG001 (MOI 10) for the depicted time-points and subsequently analyzed for LC3-I and LC3-II by immunoblotting with &#x3b2;-actin as loading control. One representative blot out of four replicates is shown. <bold>(D)</bold> LRSAM1 KO (clone #A9) and control cells (A549 NTC) were treated with 100 ng/mL Bafilomycin A1 1 h prior infection or left untreated and infected with <italic>S. aureus</italic> HG001 (MOI 10) for 3 h and subsequently analyzed for LC3-I and LC3-II expression by immunoblotting with &#x3b2;-actin as loading control, n = 3.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1597830-g004.tif">
<alt-text content-type="machine-generated">Flow cytometry and immunoblot analysis in four panels. Panel A displays dot plots indicating ubiquitination levels of HG001-GFP&#x394;spa in A549 NTC and clone #A9(-), showing reduced ubiquitination in the latter. Panel B presents a bar graph comparing percent ubiquitination between A549 NTC and clone #A9(-), with a significant decrease in clone #A9(-). Panel C shows immunoblot results for LC3-I, LC3-II, and &#x3b2;-actin over time in infected A549 NTC and clone #A9(-), indicating autophagy levels. Panel D compares LC3 and &#x3b2;-actin after bafilomycin A1 treatment, showing differential autophagic flux.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>
<italic>S. aureus</italic> infections continue to pose substantial therapeutic challenges, underscoring the necessity for novel treatment strategies. A critical concern in clinical settings is the ability of <italic>S. aureus</italic> to persist and survive within host cells, a capability that renders conventional antibiotic treatments ineffective (<xref ref-type="bibr" rid="B46">Rodrigues Lopes et&#xa0;al., 2022</xref>). Consequently, there is an imminent need to enhance our understanding of the intricate interactions between <italic>S. aureus</italic> and its host cells. The ability of <italic>S. aureus</italic> to persist intracellularly varies depending on the type of host cell. Epithelial cells are invaded by <italic>S. aureus</italic> and can serve as a reservoir for chronic or recurrent infections. This applies to keratinocytes in skin infections or epithelial cells of the respiratory tract causing pneumonia (<xref ref-type="bibr" rid="B31">Morgenstern Alexis et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B23">Lacoma et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B51">Stelzner et&#xa0;al., 2021</xref>). Epithelial cells represent the first line of defense against invading pathogens. While these cells do not actively phagocytose, studies have demonstrated the ability of <italic>S. aureus</italic> to invade, survive, and persist within these cells especially by formation of the SCV phenotype (<xref ref-type="bibr" rid="B58">Tuchscherr et&#xa0;al., 2010</xref>, <xref ref-type="bibr" rid="B59">2011</xref>; <xref ref-type="bibr" rid="B41">Proctor et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B20">Kahl et&#xa0;al., 2016</xref>). However, host cells have evolved mechanisms to combat and eliminate bacteria. A more profound understanding of these processes will facilitate the development of novel strategies for treating <italic>S. aureus</italic> infections.</p>
<p>In this study, we examined the function of the ubiquitin E3 ligase LRSAM1 in the recognition and elimination of intracellular <italic>S. aureus</italic> HG001 in A549 alveolar epithelial cells. Consequently, HG001 has been employed to study intracellular host-pathogen interactions, as it is capable of surviving and replicating within the intracellular environment (<xref ref-type="bibr" rid="B28">Mauthe et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B53">Surmann et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B37">Palma Medina et&#xa0;al., 2019</xref>). Our experimental infection model, which utilized the infection of A549 NTC cells as controls, corroborated these findings, displaying intracellular bacterial survival, low levels of cell death, and low secretion of the cytokine IL-6.</p>
<p>Upon deletion of LRSAM1 this phenotype dramatically changed. We observed a higher infection rate and larger numbers of intracellular bacteria indicating that LRSAM1 is critical for controlling intracellular <italic>S. aureus</italic>. Comparable results have been obtained in a study analyzing <italic>Salmonella</italic> infections in HeLa cells where downregulation of LRSAM1 via siRNA increased the intracellular numbers of <italic>Salmonella</italic> significantly (<xref ref-type="bibr" rid="B19">Huett et&#xa0;al., 2012</xref>). Moreover, we could demonstrate that the invasion of <italic>S. aureus</italic> in general depends on bacterial viability. Besides the increased bacterial load, we observed a higher infection rate, which might indicate an increased susceptibility of the host cells to bacterial invasion (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). A reason for this might be LRSAM1&#x2019;s ubiquitin ligase activity which has been shown to influence receptor sorting during endocytosis by regulating key endosomal sorting proteins, particularly tumor susceptibility gene 101 (TSG101), a core component of the endosomal sorting complex required for transport-I (ESCRT-I) complex, which is essential for the endosomal sorting and lysosomal degradation of receptors such as the epidermal growth factor receptor (<xref ref-type="bibr" rid="B30">Mishra et&#xa0;al., 2019</xref>). In contrast, studies of <italic>Salmonella</italic> infection showed that knockdown of the autophagy receptors NDP52 and p62, which are responsible for recognizing ubiquitinated <italic>Salmonella</italic>, had no effect on the susceptibility of cells to the bacteria (<xref ref-type="bibr" rid="B55">Thurston et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B62">Zheng et&#xa0;al., 2009</xref>).</p>
<p>Many studies documented the ability of <italic>S. aureus</italic> to induce host cell death, a process frequently characterized by the activation of programmed cell death pathways, including apoptosis, necroptosis, and inflammasome-mediated pyroptosis (<xref ref-type="bibr" rid="B9">Esen et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B16">Haslinger-L&#xf6;ffler et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B14">Greenlee-Wacker et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B29">Melehani et&#xa0;al., 2015</xref>). In accordance with these findings, our results revealed an increase in apoptotic and necroptotic cell death during infection, which was more pronounced in LRSAM1-deficient cells. It is important to note that other studies analyzing host cell death mechanisms upon <italic>S. aureus</italic> infection applied higher MOIs (&#x2265;50) than used in our experimental set up. Our findings suggest the following scenario: LRSAM1 deletion results in elevated intracellular bacterial levels, which lead to higher induction of apoptosis and increased necroptosis compared to NTC control cells. However, no pyroptotic cell death was observed (data not shown). In addition, the induction of cell death depends on the active expression of virulence factors by viable <italic>S. aureus</italic>. Therefore, PFA-fixed <italic>S. aureus</italic> had no impact on these processes in A549 cells. The same has also been shown for HUVEC cells, for which apoptosis induction requires staphylococcal invasion and metabolically active intracellular staphylococci (<xref ref-type="bibr" rid="B16">Haslinger-L&#xf6;ffler et&#xa0;al., 2005</xref>). Moreover, a high intracellular bacterial load in the LRSAM1-deficient cells could also explain the increased activation of the NF&#x3ba;B pathway, which subsequently leads to the profound IL-6 secretion observed. Similar results were shown for keratinocytes infected with <italic>S. aureus</italic> 8325-4, where a clear relationship between the amount of intracellular <italic>S. aureus</italic> and IL-6 production was demonstrated (<xref ref-type="bibr" rid="B34">Ngo et&#xa0;al., 2022</xref>). However, since the uninfected LRSAM KO cells also showed a slight increase in IL6 secretion, it is possible that LRSAM1 KO cells are more sensitive to extracellular stimuli for cytokine secretion. One possible reason for this is the proposed role of LRSAM1 in receptor endocytosis. The ubiquitination of the endosomal sorting protein TSG101 has been shown to be essential for the lysosomal degradation of receptors (<xref ref-type="bibr" rid="B30">Mishra et&#xa0;al., 2019</xref>). A LRSAM1 knockout may stabilize surface receptors, thereby sensitizing the cells to extracellular stimuli, which may manifest at later time points due to e.g., cells&#x2019; high confluency.</p>
<p>Ubiquitination of bacteria is crucial for their elimination via selective autophagy (<xref ref-type="bibr" rid="B13">Goodall et&#xa0;al., 2022</xref>). Assessing surface ubiquitination of <italic>S. aureus</italic> revealed a significant reduction; however, ubiquitination was not abrogated in LRSAM1-deficient cells. This suggests that other E3 ligases may partially compensate for the loss of LRSAM1. The reduced ubiquitination in LRSAM1-deficiency may explain the observed increase in intracellular bacteria. To date, few E3 ligases are known to ubiquitinate intracellular bacteria. RNF213 is implicated in recognizing lipopolysaccharide (LPS) and ubiquitinating <italic>Salmonella</italic> (<xref ref-type="bibr" rid="B36">Otten et&#xa0;al., 2021</xref>). PARKIN and SMURF1 have been associated with <italic>M. tuberculosis</italic> ubiquitination (<xref ref-type="bibr" rid="B27">Manzanillo et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Franco et&#xa0;al., 2017</xref>). Additionally, ARIH1 has been observed on <italic>Salmonella</italic> surfaces prior to LRSAM1 during infection (<xref ref-type="bibr" rid="B39">Polajnar et&#xa0;al., 2017</xref>). This highlights the complexity of the host&#x2019;s ubiquitination machinery in response to intracellular pathogens. Variations in the type of ubiquitin chain catalyzed by different E3 ligases may further affect the efficiency with which <italic>S. aureus</italic> is targeted by selective autophagy. We observed both K48- and K63-linked ubiquitin chains at the surface of <italic>S. aureus</italic>. Since both chain-types were reduced in the LRSAM1 KO, LRSAM1 may be responsible for the generation of these chains. Although LRSAM1 has been shown to be capable of creating all ubiquitin linkage types except M1, it is known to preferentially create K6 and K27 ubiquitin chains (<xref ref-type="bibr" rid="B19">Huett et&#xa0;al., 2012</xref>) whereas other E3 ligases such as PARKIN and SMURF1 facilitate K63 and K48 ubiquitin chains, respectively, on intracellular <italic>M. tuberculosis</italic> (<xref ref-type="bibr" rid="B27">Manzanillo et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Franco et&#xa0;al., 2017</xref>). As LRSAM1 is not the only E3 ligase responsible for ubiquitinating <italic>S. aureus</italic>, future studies must address which observed linkage types might be attributed to LRSAM1 or alternative E3 ligases, which may act alone or together with LRSAM1 in a &#x201c;bacteria-recognition-complex&#x201d;. In spite of the reduced ubiquitination, we observed a robust induction of autophagy, as evidenced by elevated levels of LC3-II. Given that LC3-II is degraded along with its bound cargo within the autophagosomes, elevated levels of LC3-II may indicate either a blocked autophagic pathway or an augmented autophagic flux. Treatment with bafilomycin, which impedes the fusion of the autophagosomes with lysosomes, resulted in accumulation of LC3-II, suggesting an increased autophagic flux. The overall role of autophagy in <italic>S. aureus</italic> infection remains controversial in the literature. In addition to its proposed role in eliminating intracellular bacteria, there is evidence that autophagosomes may serve as intracellular niches that are essential for <italic>S. aureus</italic> replication (<xref ref-type="bibr" rid="B47">Schnaith et&#xa0;al., 2007</xref>). The marked induction of autophagy in LRSAM1-deficient cells during <italic>S. aureus</italic> infection suggests a potential exploitation of autophagy for replication by <italic>S. aureus</italic>. On the other hand, it has been proposed that <italic>S. aureus</italic> can actively evade autophagy-mediated degradation by manipulating the host MAPkinase p38 during the infection process resulting in bacterial replication in the cytosol (<xref ref-type="bibr" rid="B33">Neumann et&#xa0;al., 2016</xref>). Moreover, it has been shown that <italic>S. aureus</italic> can induce autophagy without being targeted to autophagosomal degradation, by modifying the host cell metabolism, thereby, inducing starvation-induced autophagy, resulting in the production of <italic>S. aureus</italic>-free autophagosomes within HeLa cells (<xref ref-type="bibr" rid="B4">Bravo-Santano et&#xa0;al., 2018</xref>). In addition, pattern recognition receptors (PRRs), notably Toll-like receptor 2, sense bacterial components and influence autophagy signaling pathways (<xref ref-type="bibr" rid="B60">Wang et&#xa0;al., 2022</xref>), thereby inducing autophagy in response to infection. The varied outcomes observed in the host cellular responses to intracellular <italic>S. aureus</italic> may be indicative of the diverse strain-specific differences in intracellular survival, which are often attributable to differential expression of bacterial virulence factors. Additionally, the type of host cell infected makes a great difference as well (<xref ref-type="bibr" rid="B15">Grosz et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B1">Bayer et&#xa0;al., 2024</xref>).</p>
<p>Taken together, our data show a pivotal role for LRSAM1 in <italic>S. aureus</italic> HG001 ubiquitination and elimination via selective autophagy. Our current simplified model, highlighted in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, suggests that LRSAM1 ubiquitinates intracellular <italic>S. aureus</italic> in the cytoplasm upon infection. The ubiquitinated bacteria are recognized by autophagic adaptor proteins such as NDP52 and p62, which mediate interaction with LC3, leading to phagosome maturation and ultimately lysosome fusion, which eliminates the bacteria. In LRSAM1-deficient cells, this pathway is shut down. However, alternative E3 ligases can compensate for the loss of LRSAM1, resulting in partial ubiquitination and potential differences in the type of ubiquitination and ubiquitin chain linkages that compromises subsequent autophagy. Therefore, the host cell has a reduced capacity to eliminate <italic>S. aureus</italic>, leading to uncontrolled intracellular replication, a &#x201c;paradoxical&#x201d; increase in total autophagic activity and induction of programmed host cell death. Several questions remain to be addressed in future research. For example, is there a chronological sequence of different E3 ligases whose activity builds on each other, and what are the actual targets that are ubiquitinated on the bacterial surface?</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Model of ubiquitination and subsequent elimination of <italic>S. aureus</italic> via LRSAM1. <italic>S. aureus</italic> is ubiquitinated by LRSAM1 within the cytosol. The ubiquitinated bacteria are recognized by autophagy adaptor proteins, including NDP52 and p62, which facilitate interaction with LC3, resulting in phagosome maturation and subsequent fusion with lysosomes, leading to bacterial elimination. In the absence of LRSAM1, alternative E3 ligases can compensate the loss of ubiquitination by LRSAM1 ubiquitinating <italic>S. aureus</italic> albeit to a lesser extent or attaching different ubiquitin chains. This, in turn, reduces the recognition of <italic>S. aureus</italic> by the autophagic adaptor proteins, thereby facilitating its intracellular survival and replication.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1597830-g005.tif">
<alt-text content-type="machine-generated">Diagram illustrating the role of LRSAM1 and other E3 ligases in the autophagy of Staphylococcus aureus. Ubiquitin tags the bacteria, leading to phagophore formation and autophagosome creation. LRSAM1 knockout (KO) disrupts this process, resulting in bacterial survival and replication. The process involves various components like autophagy receptors and LC3 inside cellular structures, ending in lysosomal elimination of the bacteria.</alt-text>
</graphic>
</fig>
<p>Our findings contribute to the understanding of how <italic>S. aureus</italic> is targeted by the ubiquitination machinery of the host, particularly through LRSAM1, and how this modification influences selective autophagy and subsequent bacterial elimination. The interplay between bacterial evasion strategies and host defense mechanisms underscores the dynamic nature of host-pathogen interactions during intracellular <italic>S. aureus</italic> infection. By elucidating these intricate mechanisms, we establish a foundation for the development of alternative approaches such as the development of bacteria specific Proteolysis Targeting Chimeras (PROTACs) to force the intracellular elimination of <italic>S. aureus</italic> in patients.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>OP: Writing &#x2013; review &amp; editing, Investigation. AS: Writing &#x2013; review &amp; editing, Investigation, Writing original draft, Formal analysis. CG: Writing &#x2013; review &amp; editing, Investigation, Writing &#x2013; original draft, Formal analysis. MB: Investigation, Writing &#x2013; review &amp; editing, Visualization. KS: Resources, Writing &#x2013; review &amp; editing, Funding acquisition. UV: Writing &#x2013; review &amp; editing, Funding acquisition, Resources. BB: Writing &#x2013; review &amp; editing, Supervision, Funding acquisition. KB: Writing &#x2013; review &amp; editing, Supervision. US: Conceptualization, Writing &#x2013; review &amp; editing, Funding acquisition, Project administration. CC: Supervision, Writing &#x2013; review &amp; editing, Project administration, Writing &#x2013; original draft, Conceptualization. HW: Writing &#x2013; review &amp; editing, Investigation, Formal analysis.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Deutsche Forschungsgemeinschaft (RTG 2719). We acknowledge support for the Article Processing Charge by the German Research Foundation and the Open Access Publication Fund of the University of Greifswald.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Matthias Sendler for his support with measuring the cathepsin B activity. We thank Eylin Topfstedt for her continuous excellent technical support.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1597830/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1597830/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayer</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Gritsch</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Daiber</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Korn</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Differential survival of Staphylococcal species in macrophages</article-title>. <source>Mol. Microbiol.</source> <volume>121</volume>, <fpage>470</fpage>&#x2013;<lpage>480</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.15184</pub-id>, PMID: <pub-id pub-id-type="pmid">37898563</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Besteiro</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The role of host autophagy machinery in controlling Toxoplasma infection</article-title>. <source>Virulence</source> <volume>10</volume>, <fpage>438</fpage>&#x2013;<lpage>447</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2018.1518102</pub-id>, PMID: <pub-id pub-id-type="pmid">30269643</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birmingham</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Bakowski</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Yoshimori</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Brumell</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume>, <fpage>11374</fpage>&#x2013;<lpage>11383</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M509157200</pub-id>, PMID: <pub-id pub-id-type="pmid">16495224</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo-Santano</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ellis</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Mateos</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Calle</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Keun</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Behrends</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Intracellular staphylococcus aureus modulates host central carbon metabolism to activate autophagy</article-title>. <source>mSphere</source> <volume>3</volume>, <fpage>e00374-18</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00374-18</pub-id>, PMID: <pub-id pub-id-type="pmid">30089650</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname> <given-names>G. Y. C.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Otto</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pathogenicity and virulence of Staphylococcus aureus</article-title>. <source>Virulence</source> <volume>12</volume>, <fpage>547</fpage>&#x2013;<lpage>569</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2021.1878688</pub-id>, PMID: <pub-id pub-id-type="pmid">33522395</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Wehrly</surname> <given-names>T. D.</given-names>
</name>
<name>
<surname>Child</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Virgin</surname> <given-names>H. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Cytosolic clearance of replication-deficient mutants reveals Francisella tularensis interactions with the autophagic pathway</article-title>. <source>Autophagy</source> <volume>8</volume>, <fpage>1342</fpage>&#x2013;<lpage>1356</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.20808</pub-id>, PMID: <pub-id pub-id-type="pmid">22863802</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Jong</surname> <given-names>N. W. M.</given-names>
</name>
<name>
<surname>Van Kessel</surname> <given-names>K. P. M.</given-names>
</name>
<name>
<surname>Van Strijp</surname> <given-names>J. A. G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Immune evasion by staphylococcus aureus</article-title>. <source>Microbiol. Spectr.</source> <volume>7</volume>, <fpage>GPP3-0061-2019</fpage>. doi: <pub-id pub-id-type="doi">10.1128/microbiolspec.gpp3-0061-2019</pub-id>, PMID: <pub-id pub-id-type="pmid">30927347</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deryke</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Lodise</surname> <given-names>T. P.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Rybak</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Mckinnon</surname> <given-names>P. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia</article-title>. <source>Chest</source> <volume>128</volume>, <fpage>1414</fpage>&#x2013;<lpage>1422</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1378/chest.128.3.1414</pub-id>, PMID: <pub-id pub-id-type="pmid">16162737</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schreiner</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Jendrossek</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Lang</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Fassbender</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Grassm&#xe9;</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells</article-title>. <source>Apoptosis</source> <volume>6</volume>, <fpage>431</fpage>&#x2013;<lpage>439</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1023/A:1012445925628</pub-id>, PMID: <pub-id pub-id-type="pmid">11595832</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franco</surname> <given-names>L. H.</given-names>
</name>
<name>
<surname>Nair</surname> <given-names>V. R.</given-names>
</name>
<name>
<surname>Scharn</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Xavier</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Torrealba</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Shiloh</surname> <given-names>M. U.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The ubiquitin ligase smurf1 functions in selective autophagy of mycobacterium tuberculosis and anti-tuberculous host defense</article-title>. <source>Cell Host Microbe</source> <volume>21</volume>, <fpage>59</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2016.11.002</pub-id>, PMID: <pub-id pub-id-type="pmid">28017659</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname> <given-names>L. C.</given-names>
</name>
<name>
<surname>Dikic</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Autophagy in antimicrobial immunity</article-title>. <source>Mol. Cell</source> <volume>54</volume>, <fpage>224</fpage>&#x2013;<lpage>233</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">24766886</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf3;mez</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Reddy</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Muir</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Soong</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Pitt</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1</article-title>. <source>Nat. Med.</source> <volume>10</volume>, <fpage>842</fpage>&#x2013;<lpage>848</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm1079</pub-id>, PMID: <pub-id pub-id-type="pmid">15247912</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodall</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Kraus</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Harper</surname> <given-names>J. W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mechanisms underlying ubiquitin-driven selective mitochondrial and bacterial autophagy</article-title>. <source>Mol. Cell</source> <volume>82</volume>, <fpage>1501</fpage>&#x2013;<lpage>1513</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2022.03.012</pub-id>, PMID: <pub-id pub-id-type="pmid">35364016</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenlee-Wacker</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Kremserov&#xe1;</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Nauseef</surname> <given-names>W. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Lysis of human neutrophils by community-associated methicillin-resistant Staphylococcus aureus</article-title>. <source>Blood</source> <volume>129</volume>, <fpage>3237</fpage>&#x2013;<lpage>3244</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2017-02-766253</pub-id>, PMID: <pub-id pub-id-type="pmid">28473408</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grosz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kolter</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Paprotka</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Winkler</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Sch&#xe4;fer</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Chatterjee</surname> <given-names>S. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin &#x3b1;</article-title>. <source>Cell Microbiol.</source> <volume>16</volume>, <fpage>451</fpage>&#x2013;<lpage>465</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cmi.12233</pub-id>, PMID: <pub-id pub-id-type="pmid">24164701</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haslinger-L&#xf6;ffler</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kahl</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Grundmeier</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Strangfeld</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>U.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells</article-title>. <source>Cell. Microbiol.</source> <volume>7</volume>, <fpage>1087</fpage>&#x2013;<lpage>1097</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00533.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16008576</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ziebandt</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Ohlsen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sch&#xe4;fer</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Hecker</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Albrecht</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates</article-title>. <source>Infect. Immun.</source> <volume>78</volume>, <fpage>2877</fpage>&#x2013;<lpage>2889</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00088-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20212089</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrandt</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Surmann</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Salazar</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Normann</surname> <given-names>N.</given-names>
</name>
<name>
<surname>V&#xf6;lker</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Alternative fluorescent labeling strategies for characterizing gram-positive pathogenic bacteria: Flow cytometry supported counting, sorting, and proteome analysis of Staphylococcus aureus retrieved from infected host cells</article-title>. <source>Cytometry Part A</source> <volume>89</volume>, <fpage>932</fpage>&#x2013;<lpage>940</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cyto.a.22981</pub-id>, PMID: <pub-id pub-id-type="pmid">27643682</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huett</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Heath</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Begun</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sassi</surname> <given-names>S. O.</given-names>
</name>
<name>
<surname>Baxt</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Vyas</surname> <given-names>J. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium</article-title>. <source>Cell Host Microbe</source> <volume>12</volume>, <fpage>778</fpage>&#x2013;<lpage>790</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2012.10.019</pub-id>, PMID: <pub-id pub-id-type="pmid">23245322</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahl</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>K.</given-names>
</name>
<name>
<surname>L&#xf6;ffler</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Clinical significance and pathogenesis of staphylococcal small colony variants in persistent infections</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>29</volume>, <fpage>401</fpage>&#x2013;<lpage>427</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00069-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26960941</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalil</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Metersky</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Klompas</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Muscedere</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sweeney</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Palmer</surname> <given-names>L. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society</article-title>. <source>Clin. Infect. Dis.</source> <volume>63</volume>, <fpage>e61</fpage>&#x2013;<lpage>e111</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciw353</pub-id>, PMID: <pub-id pub-id-type="pmid">27418577</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komander</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rape</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The ubiquitin code</article-title>. <source>Annu. Rev. Biochem.</source> <volume>81</volume>, <fpage>203</fpage>&#x2013;<lpage>229</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-biochem-060310-170328</pub-id>, PMID: <pub-id pub-id-type="pmid">22524316</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacoma</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cano</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Moranta</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Regueiro</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Dom&#xed;nguez-Villanueva</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Laabei</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Investigating intracellular persistence of Staphylococcus aureus within a murine alveolar macrophage cell line</article-title>. <source>Virulence</source> <volume>8</volume>, <fpage>1761</fpage>&#x2013;<lpage>1775</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2017.1361089</pub-id>, PMID: <pub-id pub-id-type="pmid">28762868</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamark</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kirkin</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Dikic</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Johansen</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets</article-title>. <source>Cell Cycle</source> <volume>8</volume>, <fpage>1986</fpage>&#x2013;<lpage>1990</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/cc.8.13.8892</pub-id>, PMID: <pub-id pub-id-type="pmid">19502794</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>De Lencastre</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Garau</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kluytmans</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Malhotra-Kumar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Peschel</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Methicillin-resistant staphylococcus aureus</article-title>. <source>Nat. Rev. Dis. Primers</source> <volume>4</volume>, <fpage>18033</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrdp.2018.33</pub-id>, PMID: <pub-id pub-id-type="pmid">29849094</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieber</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Todaro</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Szakal</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nelson-Rees</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells</article-title>. <source>Int. J. Cancer</source> <volume>17</volume>, <fpage>62</fpage>&#x2013;<lpage>70</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.2910170110</pub-id>, PMID: <pub-id pub-id-type="pmid">175022</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manzanillo</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Ayres</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Watson</surname> <given-names>R. O.</given-names>
</name>
<name>
<surname>Collins</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Rae</surname> <given-names>C. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>The ubiquitin ligase parkin mediates resistance to intracellular pathogens</article-title>. <source>Nature</source> <volume>501</volume>, <fpage>512</fpage>&#x2013;<lpage>516</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature12566</pub-id>, PMID: <pub-id pub-id-type="pmid">24005326</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mauthe</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Krut</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Kr&#xf6;nke</surname> <given-names>M.</given-names>
</name>
<name>
<surname>G&#xf6;tz</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Robenek</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>WIPI-1 positive autophagosome-like vesicles entrap pathogenic staphylococcus aureus for lysosomal degradation</article-title>. <source>Int. J. Cell Biol.</source> <volume>2012</volume>, <fpage>179207</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/179207</pub-id>, PMID: <pub-id pub-id-type="pmid">22829830</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melehani</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>James</surname> <given-names>D. B. A.</given-names>
</name>
<name>
<surname>Dumont</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>V. J.</given-names>
</name>
<name>
<surname>Duncan</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular</article-title>. <source>PloS Pathog.</source> <volume>11</volume>, <elocation-id>e1004970</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1004970</pub-id>, PMID: <pub-id pub-id-type="pmid">26069969</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Upadhyay</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Prajapati</surname> <given-names>V. K.</given-names>
</name>
<name>
<surname>Dhiman</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Poluri</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Jana</surname> <given-names>N. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>LRSAM1 E3 ubiquitin ligase: molecular neurobiological perspectives linked with brain diseases</article-title>. <source>Cell Mol. Life Sci.</source> <volume>76</volume>, <fpage>2093</fpage>&#x2013;<lpage>2110</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-019-03055-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30826859</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgenstern Alexis</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Peterson Liam</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Arnold Kimberly</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Brewer Matthew</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Differentiation of keratinocytes or exposure to type 2 cytokines diminishes S. aureus internalization</article-title>. <source>mSphere</source> <volume>9</volume>, <fpage>e00685</fpage>&#x2013;<lpage>e00623</lpage>. doi: 0.1128/msphere.00685-23, PMID: <pub-id pub-id-type="pmid">38501828</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Cleary</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>S. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Secondary bacterial infections associated with influenza pandemics</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2017.01041</pub-id>, PMID: <pub-id pub-id-type="pmid">28690590</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bruns</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Rohde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Prajsnar</surname> <given-names>T. K.</given-names>
</name>
<name>
<surname>Foster</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Schmitz</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Intracellular Staphylococcus aureus eludes selective autophagy by activating a host cell kinase</article-title>. <source>Autophagy</source> <volume>12</volume>, <fpage>2069</fpage>&#x2013;<lpage>2084</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2016.1226732</pub-id>, PMID: <pub-id pub-id-type="pmid">27629870</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ngo</surname> <given-names>Q. V.</given-names>
</name>
<name>
<surname>Faass</surname> <given-names>L.</given-names>
</name>
<name>
<surname>S&#xe4;hr</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hildebrand</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Eigenbrod</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Heeg</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Inflammatory Response Against Staphylococcus aureus via Intracellular Sensing of Nucleic Acids in Keratinocytes</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>828626</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.828626</pub-id>, PMID: <pub-id pub-id-type="pmid">35281009</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieto</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Espinosa</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein</article-title>. <source>Plasmid</source> <volume>49</volume>, <fpage>281</fpage>&#x2013;<lpage>285</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0147-619X(03)00020-9</pub-id>, PMID: <pub-id pub-id-type="pmid">12749839</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otten</surname> <given-names>E. G.</given-names>
</name>
<name>
<surname>Werner</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Crespillo-Casado</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Boyle</surname> <given-names>K. B.</given-names>
</name>
<name>
<surname>Dharamdasani</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Pathe</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection</article-title>. <source>Nature</source> <volume>594</volume>, <fpage>111</fpage>&#x2013;<lpage>116</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-021-03566-4</pub-id>, PMID: <pub-id pub-id-type="pmid">34012115</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palma Medina</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Michalik</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yedavally</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Raineri</surname> <given-names>E. J. M.</given-names>
</name>
<name>
<surname>Hildebrandt</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Metabolic cross-talk between human bronchial epithelial cells and internalized staphylococcus aureus as a driver for infection</article-title>. <source>Mol. Cell Proteomics</source> <volume>18</volume>, <fpage>892</fpage>&#x2013;<lpage>908</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/mcp.RA118.001138</pub-id>, PMID: <pub-id pub-id-type="pmid">30808728</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perrin</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Birmingham</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>So</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Brumell</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Recognition of bacteria in the cytosol of Mammalian cells by the ubiquitin system</article-title>. <source>Curr. Biol.</source> <volume>14</volume>, <fpage>806</fpage>&#x2013;<lpage>811</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cub.2004.04.033</pub-id>, PMID: <pub-id pub-id-type="pmid">15120074</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polajnar</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dietz</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Heilemann</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Behrends</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Expanding the host cell ubiquitylation machinery targeting cytosolic <italic>Salmonella</italic>
</article-title>. <source>EMBO Rep.</source> <volume>18</volume>, <fpage>1572</fpage>&#x2013;<lpage>1585-1585</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embr.201643851</pub-id>, PMID: <pub-id pub-id-type="pmid">28784601</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponpuak</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Delgado</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Dinkins</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties</article-title>. <source>Immunity</source> <volume>32</volume>, <fpage>329</fpage>&#x2013;<lpage>341</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2010.02.009</pub-id>, PMID: <pub-id pub-id-type="pmid">20206555</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proctor</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Kriegeskorte</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kahl</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>K.</given-names>
</name>
<name>
<surname>L&#xf6;ffler</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>4</volume>, <elocation-id>99</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2014.00099</pub-id>, PMID: <pub-id pub-id-type="pmid">25120957</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proctor</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Von Eiff</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kahl</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Mcnamara</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Herrmann</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>4</volume>, <fpage>295</fpage>&#x2013;<lpage>305</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro1384</pub-id>, PMID: <pub-id pub-id-type="pmid">16541137</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ran</surname> <given-names>F. A.</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>P. D.</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Agarwala</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Genome engineering using the CRISPR-Cas9 system</article-title>. <source>Nat. Protoc.</source> <volume>8</volume>, <fpage>2281</fpage>&#x2013;<lpage>2308</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id>, PMID: <pub-id pub-id-type="pmid">24157548</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R&#xe4;th</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ziesemer</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Witte</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Konkel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hildebrandt</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>&#x2009;aureus haemolysin A-induced IL-8 and IL-6 release from human airway epithelial cells is mediated by activation of p38- and Erk-MAP kinases and additional, cell type-specific signalling mechanisms</article-title>. <source>Cell. Microbiol.</source> <volume>15</volume>, <fpage>1253</fpage>&#x2013;<lpage>1265</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cmi.12113</pub-id>, PMID: <pub-id pub-id-type="pmid">23347173</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravenhill</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Boyle</surname> <given-names>K. B.</given-names>
</name>
<name>
<surname>Von Muhlinen</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ellison</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Masson</surname> <given-names>G. R.</given-names>
</name>
<name>
<surname>Otten</surname> <given-names>E. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>The cargo receptor NDP52 initiates selective autophagy by recruiting the ULK complex to cytosol-invading bacteria</article-title>. <source>Mol. Cell</source> <volume>74</volume>, <fpage>320</fpage>&#x2013;<lpage>329.e6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2019.01.041</pub-id>, PMID: <pub-id pub-id-type="pmid">30853402</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues Lopes</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Alcantara</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Josse</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Vega</surname> <given-names>E. P.</given-names>
</name>
<name>
<surname>Cabrerizo</surname> <given-names>A. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Microscopy-based phenotypic profiling of infection by Staphylococcus aureus clinical isolates reveals intracellular lifestyle as a prevalent feature</article-title>. <source>Nat. Commun.</source> <volume>13</volume>, <fpage>7174</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-022-34790-9</pub-id>, PMID: <pub-id pub-id-type="pmid">36418309</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schnaith</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kashkar</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Leggio</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Addicks</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kr&#xf6;nke</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Krut</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume>, <fpage>2695</fpage>&#x2013;<lpage>2706</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M609784200</pub-id>, PMID: <pub-id pub-id-type="pmid">17135247</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sendler</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Maertin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>John</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Persike</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>F. U.</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Cathepsin B activity initiates apoptosis via digestive protease activation in pancreatic acinar cells and experimental pancreatitis</article-title>. <source>J. Biol. Chem.</source> <volume>291</volume>, <fpage>14717</fpage>&#x2013;<lpage>14731</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M116.718999</pub-id>, PMID: <pub-id pub-id-type="pmid">27226576</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Verma</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Seranova</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Sarkar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Selective autophagy and xenophagy in infection and disease</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2018.00147</pub-id>, PMID: <pub-id pub-id-type="pmid">30483501</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoji-Kawata</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Levine</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Autophagy, antiviral immunity, and viral countermeasures</article-title>. <source>Biochim. Biophys. Acta (BBA) - Mol. Cell Res.</source> <volume>1793</volume>, <fpage>1478</fpage>&#x2013;<lpage>1484</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamcr.2009.02.008</pub-id>, PMID: <pub-id pub-id-type="pmid">19264100</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stelzner</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Boyny</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hertlein</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sroka</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Moldovan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Paprotka</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Intracellular Staphylococcus aureus employs the cysteine protease staphopain A to induce host cell death in epithelial cells</article-title>. <source>PloS Pathog.</source> <volume>17</volume>, <elocation-id>e1009874</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1009874</pub-id>, PMID: <pub-id pub-id-type="pmid">34473800</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strobel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pf&#xf6;rtner</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Tuchscherr</surname> <given-names>L.</given-names>
</name>
<name>
<surname>V&#xf6;lker</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Kramko</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>22</volume>, <fpage>799</fpage>&#x2013;<lpage>809</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmi.2016.06.020</pub-id>, PMID: <pub-id pub-id-type="pmid">27393124</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surmann</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Michalik</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hildebrandt</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gierok</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Depke</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brinkmann</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Comparative proteome analysis reveals conserved and specific adaptation patterns of Staphylococcus aureus after internalization by different types of human non-professional phagocytic host cells</article-title>. <source>Front. Microbiol.</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2014.00392</pub-id>, PMID: <pub-id pub-id-type="pmid">25136337</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surmann</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hildebrandt</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Pf&#xf6;rtner</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Michalik</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Stentzel</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>A proteomic perspective of the interplay of Staphylococcus aureus and human alveolar epithelial cells during infection</article-title>. <source>J. Proteomics</source> <volume>128</volume>, <fpage>203</fpage>&#x2013;<lpage>217</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jprot.2015.07.034</pub-id>, PMID: <pub-id pub-id-type="pmid">26244908</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thurston</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Ryzhakov</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Bloor</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Von Muhlinen</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Randow</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria</article-title>. <source>Nat. Immunol.</source> <volume>10</volume>, <fpage>1215</fpage>&#x2013;<lpage>1221</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1800</pub-id>, PMID: <pub-id pub-id-type="pmid">19820708</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Eichenberger</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Holland</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Fowler</surname> <given-names>V. G.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group> (<year>2015</year>). <article-title>Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>28</volume>, <fpage>603</fpage>&#x2013;<lpage>661</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00134-14</pub-id>, PMID: <pub-id pub-id-type="pmid">26016486</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Niederman</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Chastre</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ewig</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fernandez-Vandellos</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Hanberger</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci&#xf3;n Latinoamericana del T&#xf3;rax (ALAT)</article-title>. <source>Eur. Respir. J.</source>, <fpage>50</fpage> (<issue>3</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.1183/13993003.00582-2017</pub-id>, PMID: <pub-id pub-id-type="pmid">28890434</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuchscherr</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Heitmann</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Viemann</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Von Eiff</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence</article-title>. <source>J. Infect. Dis.</source> <volume>202</volume>, <fpage>1031</fpage>&#x2013;<lpage>1040</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/656047</pub-id>, PMID: <pub-id pub-id-type="pmid">20715929</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuchscherr</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Medina</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>M.</given-names>
</name>
<name>
<surname>V&#xf6;lker</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Heitmann</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Niemann</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection</article-title>. <source>EMBO Mol. Med.</source> <volume>3</volume>, <fpage>129</fpage>&#x2013;<lpage>141</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/emmm.201000115</pub-id>, PMID: <pub-id pub-id-type="pmid">21268281</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Domain fusion TLR2-4 enhances the autophagy-dependent clearance of Staphylococcus aureus in the genetic engineering goat</article-title>. <source>eLife</source> <volume>11</volume>, <elocation-id>e78044</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.78044.sa2</pub-id>, PMID: <pub-id pub-id-type="pmid">35762728</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watson</surname> <given-names>R. O.</given-names>
</name>
<name>
<surname>Manzanillo</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway</article-title>. <source>Cell</source> <volume>150</volume>, <fpage>803</fpage>&#x2013;<lpage>815</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2012.06.040</pub-id>, PMID: <pub-id pub-id-type="pmid">22901810</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shahnazari</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Brech</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lamark</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Johansen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Brumell</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway</article-title>. <source>J. Immunol. (Baltimore Md.: 1950)</source> <volume>183</volume>, <fpage>5909</fpage>&#x2013;<lpage>5916</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0900441</pub-id>, PMID: <pub-id pub-id-type="pmid">19812211</pub-id></citation></ref>
</ref-list>
</back>
</article>